The aim of the study was to characterise the humoral response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with diabetes. Demonstrating the ability to mount an appropriate antibody response in the presence of hyperglycaemia is relevant for the comprehension of mechanisms related to the observed worse clinical outcome of coronavirus disease 2019 (COVID-19) pneumonia in patients with diabetes and for the development of any future vaccination campaign to prevent SARS-CoV-2 infection.

Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study / Lampasona, Vito; Secchi, Massimiliano; Scavini, Marina; Bazzigaluppi, Elena; Brigatti, Cristina; Marzinotto, Ilaria; Davalli, Alberto; Caretto, Amelia; Laurenzi, Andrea; Martinenghi, Sabina; Molinari, Chiara; Vitali, Giordano; Di Filippo, Luigi; Mercalli, Alessia; Melzi, Raffaella; Tresoldi, Cristina; Rovere-Querini, Patrizia; Landoni, Giovanni; Ciceri, Fabio; Bosi, Emanuele; Piemonti, Lorenzo. - In: DIABETOLOGIA. - ISSN 0012-186X. - 63:12(2020), pp. 2548-2558. [10.1007/s00125-020-05284-4]

Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study

Marzinotto, Ilaria;Laurenzi, Andrea;Di Filippo, Luigi;Rovere-Querini, Patrizia;Landoni, Giovanni;Ciceri, Fabio;Bosi, Emanuele
Penultimo
;
Piemonti, Lorenzo
Ultimo
2020-01-01

Abstract

The aim of the study was to characterise the humoral response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with diabetes. Demonstrating the ability to mount an appropriate antibody response in the presence of hyperglycaemia is relevant for the comprehension of mechanisms related to the observed worse clinical outcome of coronavirus disease 2019 (COVID-19) pneumonia in patients with diabetes and for the development of any future vaccination campaign to prevent SARS-CoV-2 infection.
2020
8-ott-2020
Inglese
63
12
2548
2558
11
Pubblicato
Esperti anonimi
Internazionale
Antibodies
COVID-19
Diabetes
Human
Humoral response
Receptor-binding domain
SARS-CoV-2
Survival rate
No
UNISR.MED
OSR
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study / Lampasona, Vito; Secchi, Massimiliano; Scavini, Marina; Bazzigaluppi, Elena; Brigatti, Cristina; Marzinotto, Ilaria; Davalli, Alberto; Caretto, Amelia; Laurenzi, Andrea; Martinenghi, Sabina; Molinari, Chiara; Vitali, Giordano; Di Filippo, Luigi; Mercalli, Alessia; Melzi, Raffaella; Tresoldi, Cristina; Rovere-Querini, Patrizia; Landoni, Giovanni; Ciceri, Fabio; Bosi, Emanuele; Piemonti, Lorenzo. - In: DIABETOLOGIA. - ISSN 0012-186X. - 63:12(2020), pp. 2548-2558. [10.1007/s00125-020-05284-4]
none
21
info:eu-repo/semantics/article
262
Lampasona, Vito; Secchi, Massimiliano; Scavini, Marina; Bazzigaluppi, Elena; Brigatti, Cristina; Marzinotto, Ilaria; Davalli, Alberto; Caretto, Amelia...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/104852
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 96
  • ???jsp.display-item.citation.isi??? 84
social impact